Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 100
Avg Vol 1,316
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 81%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally. The company offers Clozaril (clozapine tablets), an atypical antipsychotic to manage symptoms of treatment-resistant schizophrenia; CSAN Pronto device, which enhances and simplifies the mandatory safety blood monitoring process for patients that are prescribed Clozari...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 647-495-9000
Fax: 416-213-0045
Address:
10 Carlson Court, Suite 701, Etobicoke, Canada
Latest News on HLTRF
No data available.